Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Callaway Golf (NYSE: ELY), Senseonics Holdings Inc (AMEX: SENS) and American Renal Associates Holdings Inc (NYSE: ARA)

By Austin Angelo

Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Callaway Golf (NYSE: ELY), Senseonics Holdings Inc (AMEX: SENS) and American Renal Associates Holdings Inc (NYSE: ARA).

Callaway Golf (NYSE: ELY)

Callaway Golf (NYSE: ELY) received a Hold rating from Compass Point analyst Casey Alexander today. The company’s shares closed last Friday at $12.07, close to its 52-week high of $12.11.

According to TipRanks.com, Alexander is a 1-star analyst with an average return of -1.5% and a 58.8% success rate. Alexander covers the Financial sector, focusing on stocks such as TriplePoint Venture Growth, Fifth Street Finance, and Medley Capital Corp.

Callaway Golf has an analyst consensus of Strong Buy, with a price target consensus of $14.67.

Senseonics Holdings Inc (AMEX: SENS)

In a report issued on November 11, Danielle Antalffy from Leerink Swann reiterated a Buy rating on Senseonics Holdings Inc (AMEX: SENS). The company’s shares closed last Friday at $2.22, close to its 52-week low of $2.17.

According to TipRanks.com, Antalffy is a 4-star analyst with an average return of 6.5% and a 57.1% success rate. Antalffy covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp., Cardiovascular Systems, and Baxter International.

Currently, the analyst consensus on Senseonics Holdings Inc is Strong Buy and the average price target is $4.50, representing a 102.7% upside.

In a report issued on November 10, Canaccord Genuity also reiterated a Buy rating on the stock with a $6 price target.
American Renal Associates Holdings Inc (NYSE: ARA)

In a report issued on November 11, Ana Gupte from Leerink Swann reiterated a Buy rating on American Renal Associates Holdings Inc (NYSE: ARA). The company’s shares closed last Friday at $19.57.

According to TipRanks.com, Gupte is a 4-star analyst with an average return of 2.1% and a 55.3% success rate. Gupte covers the Healthcare sector, focusing on stocks such as WellCare Health Plans, Universal American, and Acadia Healthcare.

Currently, the analyst consensus on American Renal Associates Holdings Inc is Strong Buy and the average price target is $29.50, representing a 50.7% upside.

In a report issued on November 3, Barclays also reiterated a Buy rating on the stock with a $29 price target.